Literature DB >> 6359781

A solid-phase indirect haemadsorption assay (SPIHA) for detection of immunoglobulin m antibodies to Toxoplasma gondii: application to diagnosis of acute acquired toxoplasmosis.

K Hermentin, O Picher, H Aspöck, H Auer, A Hassl.   

Abstract

A solid-phase indirect haemadsorption assay (SPIHA) for the detection of immunoglobulin M (IgM) antibodies to Toxoplasma gondii is described. Polystyrol microtiter plates are coated with anti-human IgM (mu-chain-specific) antibodies and then sequentially allowed to react with patient's serum and sheep erythrocytes sensitized with soluble antigen of Toxoplasma gondii. A total of 111 sera were tested in fluorescent antibody test (FAT and IgM-FAT), complement fixation test (CFT), indirect haemagglutination assay (IHA), and in SPIHA. 47 sera were from individuals with a suspected or verified acute Toxoplasma infection. In most of these cases the SPIHA allowed a clear interpretation with respect to the status of the infection, even when the IgM-FAT was not conclusive. In contrast to IgM-FAT, rheumatoid factor or exceedingly high specific IgG antibodies did not interfere with results in SPIHA. A laboratory-acquired infection enabled us to demonstrate the course of immune response measured by SPIHA as well as by IgM-FAT, FAT, CFT, and IHA. The method proposed here is well appropriated to IgM detection, simple to perform, inexpensive, and thus representing an alternative to IgM-FAT, convenient for the routine laboratory.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6359781

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN: 0174-3031


  2 in total

1.  An anti-human immunoglobulin M monoclonal antibody for detection of antibodies to Toxoplasma gondii.

Authors:  P Pouletty; J M Pinon; M Garcia-Gonzalez; G Desmonts; P Thulliez; H Thoannes; J Kadouche
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

Review 2.  Laboratory-acquired parasitic infections from accidental exposures.

Authors:  B L Herwaldt
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.